We've just presented and published a multicenter RCT at #CCR23 and in @JAMA_current!
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The #MERCYtrial!
🔗 https://t.co/MEAGJNM2ga
This 🧵 will explain the study in detail /11
#FOAMcc
🎯 We’ve completed the #MERCYtrial!
🔀 In 29 Hospitals worldwide we’ve randomized 600 patients with sepsis or septic shock to receive standard bolus vs continuous infusion of #Meropenem
🔗 Learn more https://t.co/hI9n5wX3hP
#FOAMcc
A1/
ANTIBIOTIC QUIZ
A 60y 70kg male with normal renal function presents with septic shock attributed to pseudomonas ventilator-associated pneumonia.
What’s your #Meropenem administration strategy?
Coming up next #MERCYtrial@DrToddLee@nickmmark@iceman_ex@msiuba#FOAMcc
The investigator meeting of #MERCYTrial testing Bolus Versus Continuous Infusion of #Meropenem in Critically Ill Patients is started at @SanRaffaeleMI with numerous participants from all over Italy.